SU11. Amisulpride Augmentation of Clozapine for Treatment-Refractory Schizophrenia: The AMICUS Study

Por Barnes, Thomas, Leeson, Verity, Paton, Carol, Marston, Louise, Osborn, David, Kumar, Raj, Keown, Patrick, Zafar, Rameez, Iqbal, Khalid, Singh, Vineet, Fridrich, Pavel, Fitzgerald, Zachary, Bagalkote, Hemant, Haddad, Peter, Husni, Mariwan, Amos, Tim
Publicado no Schizophr Bull (2017)

Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial

Por Barnes, Thomas R.E., Leeson, Verity, Paton, Carol, Marston, Louise, Osborn, David P., Kumar, Raj, Keown, Patrick, Zafar, Rameez, Iqbal, Khalid, Singh, Vineet, Fridrich, Pavel, Fitzgerald, Zachary, Bagalkote, Hemant, Haddad, Peter M., Husni, Mariwan, Amos, Tim
Publicado no Ther Adv Psychopharmacol (2018)

Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.

Por Barnes, Thomas Re, Leeson, Verity C, Paton, Carol, Marston, Louise, Davies, Linda, Whittaker, William, Osborn, David, Kumar, Raj, Keown, Patrick, Zafar, Rameez, Iqbal, Khalid, Singh, Vineet, Fridrich, Pavel, Fitzgerald, Zachary, Bagalkote, Hemant, Haddad, Peter M, Husni, Mariwan, Amos, Tim
Publicado no Health Technol Assess (2017)